NEWTOWN, PENNSYLVANIA and SURREY, BRITISH COLUMBIA--(Marketwired - Aug. 31, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company") is pleased to announce HealthTech Connex Inc. ("HTC") in Surrey, British Columbia, will be the fourth site for the company's ongoing pivotal trial investigating PoNS™ Therapy for the treatment of subjects with balance disorder resulting from mild to moderate Traumatic Brain Injury (TBI). Clinical trial sites in the U.S. and Canada include the Montreal Neurofeedback Center, Oregon Health and Science University and Orlando Regional Medical Center.
"We are thrilled to be expanding our clinical presence and look forward to working with the dedicated team of professionals HTC has assembled to facilitate this study," said Helius CEO, Phil Deschamps. "The shared vision to improve care for those suffering from brain injuries connected Helius with HealthTech Connex. Their expertise in neurotechnology, brain imaging and brain trauma, as well as their broad network in the TBI community provides a sound foundation for adding this fourth PoNS™ clinical trial site."
"HealthTech Connex is excited to be a service provider for Helius, with our new facilities at the Health & Technology District in Surrey," said Dr. Ryan D'Arcy, HTC President & Chief Scientific Officer. "Furthering the understanding of neuroplasticity and pioneering treatments for brain injury are our common goals as we investigate potential solutions to this considerable unmet medical need."
Ad Statistics
Times Displayed: 22687
Times Visited: 478 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
To learn more about the clinical trial, the clinical trial sites and recruitment opportunities please visit www.heliusmedical.com/our-research/clinical-trials.
About PoNS™ Therapy
The Portable Neuromodulation Stimulator (PoNS™) is an investigational non-invasive device designed to deliver neurostimulation through the tongue. PoNS™ Therapy combines the use of the device with physical therapy and is currently being evaluated in a multicenter clinical trial for the treatment of balance disorder for subjects with mild to moderate Traumatic Brain Injury.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a medical technology company focused on neurological wellness. Helius seeks to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. Helius intends to file for FDA clearance for the PoNS™ device. For more information, please visit www.heliusmedical.com.
About HealthTech Connex Inc.
HealthTech Connex, Inc. is a health technology company working to revolutionize the practice of clinical neuroscience through advanced technologies based on the highest quality science and innovation. Located in Surrey, British Columbia, Canada, it is one of the first companies to emerge from the city's Innovation Boulevard, an agile partnership of health, business, higher education and government creating new health technologies to improve peoples' lives. www.HTCBrainVitalSigns.com
The Toronto Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
